Tetratherix Limited (ASX:TTX)
Australia
· Delayed Price · Currency is AUD 3.880
-0.090 (-2.27%)
At close: Mar 6, 2026
Tetratherix Company Description
Tetratherix Limited engages in biomaterial and regenerative medicine business in Australia and internationally.
The company manufactures and commercialize medical device in the areas of bone regeneration, tissue spacing, and tissue healing applications through its Tetramatrix platform technology.
Tetratherix Limited was incorporated in 2015 and is based in Alexandria, Australia.
Tetratherix Limited
| Country | Australia |
| Founded | 2015 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 15 |
| CEO | William Knox |
Contact Details
Address: Unit 29 Alexandria, NSW 2015 Australia | |
| Website | tetratherix.com |
Stock Details
| Ticker Symbol | TTX |
| Exchange | Australian Securities Exchange |
| Fiscal Year | July - June |
| Reporting Currency | AUD |
| ISIN Number | AU0000400574 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| William Anthony Knox | Chief Executive Officer, MD and Executive Director |
| Dr. Ali Fathi | Founder, Chief Technology Officer and Executive Director |
| Terence Abrams | Founder and Chief Operating Officer |
| Cherie Beach | Chief Financial Officer |
| Jacob Pfeffer | General Counsel and Company Secretary |
| Alex Washington | Financial Controller |